Skip to main content

NextCure, Inc.

NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001661059

In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in NextCure, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−4 vs. Q2 2024
Shares held
15.9M
+616.2K (+4.0%) vs. Q2 2024
Total value
$21.7M
−$2.51M (−10.4%) vs. Q2 2024
New holders
3
8 more added
Sold out
7
10 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 44 institutions
Q1 2021: 92 institutionsQ2 2021: 78 institutionsQ3 2021: 71 institutionsQ4 2021: 71 institutionsQ1 2022: 59 institutionsQ2 2022: 51 institutionsQ3 2022: 52 institutionsQ4 2022: 45 institutionsQ1 2023: 44 institutionsQ2 2023: 43 institutionsQ3 2023: 41 institutionsQ4 2023: 43 institutionsQ1 2024: 47 institutionsQ2 2024: 49 institutionsQ3 2024: 44 institutionsQ4 2024: 46 institutionsQ1 2025: 38 institutionsQ2 2025: 30 institutionsQ3 2025: 17 institutionsQ4 2025: 24 institutionsQ1 2026: 26 institutionsQ2 2026: 30 institutions
Value heldQ3 2024: $21.7M
Q1 2021: $179.8MQ2 2021: $124.2MQ3 2021: $99.5MQ4 2021: $86.2MQ1 2022: $64.3MQ2 2022: $67.9MQ3 2022: $41.8MQ4 2022: $18.9MQ1 2023: $19.6MQ2 2023: $24.0MQ3 2023: $16.6MQ4 2023: $15.3MQ1 2024: $36.0MQ2 2024: $25.5MQ3 2024: $21.7MQ4 2024: $13.1MQ1 2025: $7.38MQ2 2025: $5.65MQ3 2025: $5.03MQ4 2025: $26.9MQ1 2026: $23.0MQ2 2026: $2.78M
Institutions holding NXTC and their total value by quarter
QuarterHoldersValue
Q2 202630$2.78M
Q1 202626$23.0M
Q4 202524$26.9M
Q3 202517$5.03M
Q2 202530$5.65M
Q1 202538$7.38M
Q4 202446$13.1M
Q3 202444$21.7M
Q2 202449$25.5M
Q1 202447$36.0M
Q4 202343$15.3M
Q3 202341$16.6M
Q2 202343$24.0M
Q1 202344$19.6M
Q4 202245$18.9M
Q3 202252$41.8M
Q2 202251$67.9M
Q1 202259$64.3M
Q4 202171$86.2M
Q3 202171$99.5M
Q2 202178$124.2M
Q1 202192$179.8M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q2 2024.

Institutions holding NXTC in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Sofinnova Investments, Inc.2,671,856$3.66M0.30%00.0%Unchanged
Logos Global Management LP2,500,000$3.42M0.38%00.0%Unchanged
Affinity Asset Advisors, LLC2,302,598$3.15M0.49%+614,643+36.4%Added
OrbiMed Advisors LLC1,141,200$1.56M0.03%00.0%Unchanged
Vanguard Group Inc987,324$1.35M0.00%00.0%Unchanged
BlackRock, Inc.729,836$999.9K0.00%+729,836New
Tang Capital Management LLC652,386$893.8K0.06%+49,392+8.2%Added
Cable Car Capital LLC615,878$843.8K0.91%00.0%Unchanged
Long Focus Capital Management, LLC556,105$761.9K0.07%00.0%Unchanged
Acadian Asset Management LLC488,440$667.0K0.00%00.0%Unchanged
Renaissance Technologies LLC406,000$556.2K0.00%−56,144−12.1%Reduced
Acuitas Investments, LLC342,592$469.4K0.21%+19,250+6.0%Added
Federated Hermes, Inc.321,527$440.5K0.00%−5,878−1.8%Reduced
BML Capital Management, LLC276,465$378.8K0.22%00.0%Unchanged
Cardiff Park Advisors, LLC262,000$358.9K0.03%00.0%Unchanged
Geode Capital Management, LLC223,741$306.6K0.00%+27,812+14.2%Added
Macquarie Group Ltd150,000$206.0K0.00%00.0%Unchanged
Sio Capital Management, LLC130,000$178.1K0.08%00.0%Unchanged
ADAR1 Capital Management, LLC120,013$164.4K0.03%+30,999+34.8%Added
Hudson Bay Capital Management LP107,672$147.5K0.00%−96,128−47.2%Reduced
Armistice Capital, LLC100,000$137.0K0.00%+64,000+177.8%Added
Dimensional Fund Advisors LP85,853$117.6K0.00%−706−0.8%Reduced
Assenagon Asset Management S.A.85,308$116.9K0.00%−99,178−53.8%Reduced
Millennium Management LLC72,119$98.8K0.00%−386,221−84.3%Reduced
Bridgeway Capital Management, LLC70,600$96.7K0.00%00.0%Unchanged
Barclays PLC67,518$92.5K0.00%00.0%Unchanged
State Street Corp65,392$89.6K0.00%00.0%Unchanged
Marquette Asset Management, LLC58,259$79.8K0.01%00.0%Unchanged
Citadel Advisors LLC55,954$76.7K0.00%−233,096−80.6%Reduced
Northern Trust Corp47,562$65.2K0.00%00.0%Unchanged
Ieq Capital, LLC37,342$51.2K0.00%00.0%Unchanged
LPL Financial LLC27,000$37.0K0.00%−3,000−10.0%Reduced
Schonfeld Strategic Advisors LLC23,800$32.6K0.00%−3,800−13.8%Reduced
Walleye Capital LLC21,247$29.1K0.00%00.0%Unchanged
HSBC Holdings PLC17,363$23.7K0.00%00.0%Unchanged
Engineers Gate Manager LP10,774$14.8K0.00%+10,774New
HarbourVest Partners LLC10,044$13.8K0.01%00.0%Unchanged
Charles Schwab Investment Management Inc10,000$13.7K0.00%00.0%Unchanged
UBS Group AG5,466$7.49K0.00%−4,462−44.9%Reduced
Bank of America Corp5,390$7.38K0.00%+21+0.4%Added
Advisor Group Holdings, Inc.1,191$1.63K0.00%+1,191New
JPMorgan Chase & Co807$1.11K0.00%+1+0.1%Added
BNP Paribas Arbitrage, SA385$5270.00%00.0%Unchanged
Morgan Stanley1$10.00%00.0%Unchanged
XTX Topco Ltd0$00.00%−20,874−100.0%Sold out
Jane Street Group, LLC0$00.00%−19,342−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−1,227−100.0%Sold out
Rhumbline Advisers0$00.00%−703−100.0%Sold out
Royal Bank of Canada0$00.00%−403−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−48−100.0%Sold out
Simplex Trading, LLC0$00.00%−547−100.0%Sold out
BlackRock Inc.––––Not filed